This company has been marked as potentially delisted and may not be actively trading. Cesca Therapeutics (KOOL) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsDividendOwnershipTrendsBuy This Stock KOOL vs. THMO, KEQU, TLSA, AVR, ORMP, OPTN, COYA, CLYM, QIPT, and BDSXShould you be buying Cesca Therapeutics stock or one of its competitors? The main competitors of Cesca Therapeutics include ThermoGenesis (THMO), Kewaunee Scientific (KEQU), Tiziana Life Sciences (TLSA), Anteris Technologies Global (AVR), Oramed Pharmaceuticals (ORMP), OptiNose (OPTN), Coya Therapeutics (COYA), Climb Bio (CLYM), Quipt Home Medical (QIPT), and Biodesix (BDSX). Cesca Therapeutics vs. ThermoGenesis Kewaunee Scientific Tiziana Life Sciences Anteris Technologies Global Oramed Pharmaceuticals OptiNose Coya Therapeutics Climb Bio Quipt Home Medical Biodesix ThermoGenesis (NASDAQ:THMO) and Cesca Therapeutics (NASDAQ:KOOL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings, media sentiment and community ranking. Do insiders & institutionals hold more shares of THMO or KOOL? 5.8% of ThermoGenesis shares are owned by institutional investors. Comparatively, 3.1% of Cesca Therapeutics shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by company insiders. Comparatively, 68.9% of Cesca Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, THMO or KOOL? ThermoGenesis has a beta of 2.47, meaning that its share price is 147% more volatile than the S&P 500. Comparatively, Cesca Therapeutics has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500. Does the MarketBeat Community believe in THMO or KOOL? Cesca Therapeutics received 241 more outperform votes than ThermoGenesis when rated by MarketBeat users. Likewise, 70.45% of users gave Cesca Therapeutics an outperform vote while only 60.47% of users gave ThermoGenesis an outperform vote. CompanyUnderperformOutperformThermoGenesisOutperform Votes2660.47% Underperform Votes1739.53% Cesca TherapeuticsOutperform Votes26770.45% Underperform Votes11229.55% Does the media prefer THMO or KOOL? In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled Cesca Therapeutics'average media sentiment score. Company Overall Sentiment ThermoGenesis Neutral Cesca Therapeutics Neutral Is THMO or KOOL more profitable? ThermoGenesis has a net margin of 0.00% compared to Cesca Therapeutics' net margin of -98.84%. ThermoGenesis' return on equity of 0.00% beat Cesca Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets ThermoGenesisN/A N/A N/A Cesca Therapeutics -98.84%-77.30%-37.75% Which has preferable earnings and valuation, THMO or KOOL? ThermoGenesis has higher earnings, but lower revenue than Cesca Therapeutics. Cesca Therapeutics is trading at a lower price-to-earnings ratio than ThermoGenesis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThermoGenesis$9.61M0.00-$17.98M-$5.14N/ACesca Therapeutics$9.67M2.41-$39.72M-$3.60-2.68 SummaryThermoGenesis beats Cesca Therapeutics on 7 of the 11 factors compared between the two stocks. Get Cesca Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KOOL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KOOL vs. The Competition Export to ExcelMetricCesca TherapeuticsLaboratory Apparatus & Furniture IndustryMedical SectorNASDAQ ExchangeMarket Cap$23.35M$95.47M$5.31B$7.34BDividend Yield0.50%N/A5.45%4.35%P/E Ratio-2.685.3021.9417.81Price / Sales2.410.43380.6697.70Price / CashN/A45.3038.2534.62Price / Book3.112.466.453.98Net Income-$39.72M$18.75M$3.22B$247.75M Cesca Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KOOLCesca TherapeuticsN/A$9.66+0.4%N/A+1.6%$23.35M$9.67M-2.6853News CoverageTHMOThermoGenesisN/AN/AN/AN/A$2,000.00$9.61M0.0040KEQUKewaunee Scientific1.6012 of 5 stars$32.15-3.3%N/A-5.4%$94.88M$220.03M5.10890Short Interest ↑TLSATiziana Life Sciences0.6486 of 5 stars$0.80+1.3%N/A+60.7%$93.49MN/A0.008AVRAnteris Technologies GlobalN/A$2.58+4.5%$16.50+539.5%N/A$92.94M$2.71M0.00138News CoveragePositive NewsGap UpHigh Trading VolumeORMPOramed Pharmaceuticals1.4604 of 5 stars$2.27+7.6%N/A-5.3%$92.73M$1.34M20.6410OPTNOptiNose3.1947 of 5 stars$9.10+0.3%$9.00-1.1%-31.6%$91.66M$78.23M-2.17190Short Interest ↓Positive NewsCOYACoya Therapeutics1.7462 of 5 stars$5.45+5.4%$17.00+211.9%-34.3%$91.15M$3.55M-8.386Positive NewsCLYMClimb Bio2.4312 of 5 stars$1.31+2.3%$10.00+663.4%N/A$88.39MN/A-0.629QIPTQuipt Home Medical2.1997 of 5 stars$2.15+4.9%$6.25+190.7%-42.5%$88.34M$244.72M-12.65800Positive NewsBDSXBiodesix3.1297 of 5 stars$0.61+14.2%$2.95+387.6%-56.1%$88.32M$71.32M-1.55220Positive NewsGap Up Related Companies and Tools Related Companies THMO Alternatives KEQU Alternatives TLSA Alternatives AVR Alternatives ORMP Alternatives OPTN Alternatives COYA Alternatives CLYM Alternatives QIPT Alternatives BDSX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KOOL) was last updated on 4/21/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cesca Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cesca Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KOOL Stock Free KOOL Stock Alerts